Moreover, an interesting meta-analysis compared the efficacy of glitazones (antidiabetic and insulin-sensitizing agents) for Alzheimer’s disease (AD) and mild cognitive impairment (MCI). The gene discussed is INS; the disease is Alzheimer disease.